1. Home
  2. RVYL vs XAIR Comparison

RVYL vs XAIR Comparison

Compare RVYL & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryvyl Inc.

RVYL

Ryvyl Inc.

HOLD

Current Price

$6.31

Market Cap

9.3M

ML Signal

HOLD

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$1.19

Market Cap

10.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVYL
XAIR
Founded
2007
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3M
10.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RVYL
XAIR
Price
$6.31
$1.19
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$11.00
AVG Volume (30 Days)
838.4K
22.5M
Earning Date
11-14-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$48,858,000.00
$5,802,000.00
Revenue This Year
N/A
$127.85
Revenue Next Year
$297.49
$179.78
P/E Ratio
N/A
N/A
Revenue Growth
29.50
147.74
52 Week Low
$4.50
$0.67
52 Week High
$81.55
$10.40

Technical Indicators

Market Signals
Indicator
RVYL
XAIR
Relative Strength Index (RSI) 65.03 46.38
Support Level $5.30 $1.43
Resistance Level $7.68 $2.26
Average True Range (ATR) 1.03 0.33
MACD -0.02 -0.04
Stochastic Oscillator 39.58 20.53

Price Performance

Historical Comparison
RVYL
XAIR

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Share on Social Networks: